Pangaea Oncology, S.A. (BME:PANG)
Spain flag Spain · Delayed Price · Currency is EUR
1.470
0.00 (0.00%)
Nov 13, 2026, 4:00 PM CET

Pangaea Oncology Revenue

Pangaea Oncology had revenue of 7.63M EUR in the half year ending June 30, 2026, with 17.48% growth. This brings the company's total for the last twelve months to 15.00M, up 0.45% year-over-year. In the year 2025, Pangaea Oncology had annual revenue of 14.52M with 1.78% growth. That makes Pangaea Oncology the 34,946th largest company in the world by revenue and 157th in Spain.

Revenue (ttm)
15.00M
Revenue Growth
+0.45%
P/S Ratio
3.52
Revenue / Employee
n/a
Employees
165
Market Cap
52.84M

Revenue Chart

Revenue by Geography

  • Spain 11.46M 78.9%
  • Other 2.84M 19.5%
  • Other Countries of The European Union 223.06K 1.5%
Fiscal year ended Dec 31, 2025 See the full Pangaea Oncology breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202514.52M253.93K1.78%
Dec 31, 202414.27M6.88M93.14%
Dec 31, 20237.39M3.02M69.15%
Dec 31, 20224.37M-235.38K-5.11%
Dec 31, 20214.60M503.64K12.29%
Dec 31, 20204.10M783.11K23.61%
Dec 31, 20193.32M258.18K8.44%
Dec 31, 20183.06M436.56K16.65%
Dec 31, 20172.62M103.47K4.11%
Dec 31, 20162.52M568.73K29.17%
Dec 31, 20151.95M232.24K13.52%
Dec 31, 20141.72M-1.37M-44.40%
Dec 31, 20133.09M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.